Global Down Syndrome

Winter 2017

Issue link: https://viewer.e-digitaledition.com/i/802686

Contents of this Issue

Navigation

Page 8 of 31

By Tom Blumenthal, Ph.D., Executive Director of the Linda Crnic Institute for Down Syndrome Understanding Down Syndrome THROUGH INNOVATIVE Research SCIENTISTS AT THE LINDA CRNIC INSTITUTE FOR DOWN SYNDROME WORK COLLABORATIVELY ON PROJECTS THAT WILL ONE DAY REVEAL ANSWERS ABOUT HOW AN EXTRA COPY OF CHROMOSOME 21 IMPACTS PEOPLE WHO HAVE DOWN SYNDROME. HERE'S WHAT THEY'RE DOING NOW — AND WHAT THEY HOPE TO ACCOMPLISH IN THE FUTURE. THE CRNIC INSTITUTE is unique in that it is the first academic home for Down syndrome research. Our scientists ask probing questions with the ultimate goal of improving quality of life for people with Down syndrome. How does an extra copy of chromosome 21, the smallest human chromosome, cause all the symptoms associated with Down syndrome? How does it lead to Alzheimer's disease and cause cognitive impairment? How does it increase the incidence of leukemia and autoimmune diseases, such as Hashimoto's and Crohn's disease? How does it lower the incidence of most cancers and cardiovascular disease? The Crnic Institute has more than 100 scientists working on these answers. How did we do this? First, we brought laboratories together under one roof at the University of Colorado Anschutz Medical Campus that research these questions. Then, we organized symposia to encourage additional labs on both the Anschutz Medical Campus and the University of Colorado Boulder campus to join us. Finally, we offered money in the form of pilot grants to initiate new projects in Down syndrome research. We continue to be amazed and delighted at the response to what we call the Crnic Grand Challenge Grants Program. We receive three times the number of applications we can afford to fund. This high level of competition means we attract only successful, high-quality science to the field. However, we don't simply turn our grant recipients loose with the money. We have created a scientific community of between 50 and 70 scientists who gather every month to describe and critique these research projects. We call this our Supergroup, and it has resulted in a very collaborative environment where we share ideas, reagents, and even cells and mice. All of this adds great power to the research, compared with more siloed research performed in isolated labs. What progress has this resulted in so far? There is too much to describe in this short piece, but we can provide a few highlights. CONTINUED ON PAGE 10 Tom Blumenthal, Ph.D., Executive Director of the Linda Crnic Institute for Down Syndrome (right), with Sujeet Desai, an accomplished musician and winner of Global's Quincy Jones Exceptional Advocacy Award (lef t) GLOBALDOWNSYNDROME.ORG 9

Articles in this issue

Links on this page

Archives of this issue

view archives of Global Down Syndrome - Winter 2017